Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
29/12/2023 22:02
Dec 29 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX LTD - UNDER TERMS OF CERTAIN LOAN AGREEMENT,
DATED
MARCH 23, 2021, THE WAIVER PERIOD HAS EXPIRED AS OF TODAY,
DECEMBER 29, 2023
* LUMIRADX LTD-AMOUNT OUTSTANDING UNDER LOAN AGREEMENT OF
$361.8
MILLION WITH ACCRUED INTEREST & ALL AMOUNTS PAYABLE UNDER
AGREEMENT, IS NOW DUE AND PAYABLE
* LUMIRADX LTD-LUMIRADX INVESTMENT LIMITED IS UNABLE TO PAY
THE
OUTSTANDING AMOUNT
* LUMIRADX LTD- EXPECTS THAT THERE WILL BE NO ASSETS
AVAILABLE FOR
DISTRIBUTION TO ITS SHAREHOLDERS OR THE UNSECURED CREDITORS OF
THE LUMIRADX GROUP
Further company coverage: LMDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing